Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company JT Pharmaceuticals Inc.
DescriptionKappa opioid receptor (KOR; OPRK1) antagonist
Molecular Target Kappa opioid receptor (KOR) (OPRK1)
Mechanism of ActionKappa opioid receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat chronic peripheral pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today